Koninklijke Philips NV (PHIA)
Euronext Amsterdam · Netherlands · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 24.08 |
|---|---|
| 52-week range | 20.90 – 27.70 |
| Return, 1 month / 3 months | +11.3% / +4.7% |
| Return, 1 year / 3 years | +0.9% / +57.3% |
| Trend | Uptrend |
| RSI (14) | 76 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 33.96M EUR |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Koninklijke Philips is a Dutch technology company based in Amsterdam that focuses on health technology. It makes medical imaging systems such as scanners, ultrasound devices and patient monitoring equipment for hospitals and clinics, and it supplies software and services that support diagnosis and treatment. The company also sells personal health products, including electric shavers and oral care devices, to consumers. Its customers are mainly healthcare providers, hospitals and individual households around the world.
On this site Koninklijke Philips NV appears as a stock on the Euronext Amsterdam (Netherlands), code PHIA, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Koninklijke Philips NV (PHIA) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 24.08 on 23 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 38 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.9% and over the last three months it rose 4.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.8% | ||
| From 52-week high | -12.7% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.7% | ||
| 6-month return | 5.5% | ||
| 12-month return, skipping the last month | -9.3% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 33.96M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | +11.3% |
| 3 months | +4.7% |
| 6 months | +5.5% |
| 1 year | +0.9% |
| 3 years | +57.3% |
| 5 years | −22.6% |
Signals
| 50-day / 200-day average | 22.36 / 23.19 |
|---|---|
| Golden / death cross (60 days) | Death, 32 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.43 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 May 2026 | EUR 0.8500 |
| 12 May 2025 | EUR 0.8500 |
| 9 May 2024 | EUR 0.8790 |
| 11 May 2023 | EUR 0.9183 |
| 12 May 2022 | EUR 0.8500 |
| 10 May 2021 | EUR 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.